Moderna announces US contract for 66 million bivalent booster doses | CIDRAP

Moderna today announced a deal worth $1.76 billion with the US government to supply an initial 66 million doses for a new COVID-19 vaccine booster that targets the Omicron subvariant.

The move comes as cases continue to slowly rise, fueled by the more transmissible BA.4 and BA.5 Omicron subvariants.

Moderna’s bivalent booster shot covers the original SARS-CoV-2 virus, plus the BA.4 and BA.5 subvariants.

Source: Moderna announces US contract for 66 million bivalent booster doses | CIDRAP